Improving anti-CTLA-4 therapies through peptide masking and fragment crystallizable non‑fucosylation: preclinical characterization of three novel antibodies.

This study reports the preclinical and early clinical characterization of three next-generation anti–CTLA-4 antibodies...

Continue ReadingImproving anti-CTLA-4 therapies through peptide masking and fragment crystallizable non‑fucosylation: preclinical characterization of three novel antibodies.